首页> 外文期刊>Antimicrobial agents and chemotherapy. >Prevalence of antimicrobial resistance in respiratory tract isolates of Streptococcus pneumoniae: results of a Canadian national surveillance study. The Canadian Respiratory Infection Study Group.
【24h】

Prevalence of antimicrobial resistance in respiratory tract isolates of Streptococcus pneumoniae: results of a Canadian national surveillance study. The Canadian Respiratory Infection Study Group.

机译:肺炎链球菌呼吸道分离物中抗菌药物耐药的流行:加拿大国家监测研究的结果。加拿大呼吸道感染研究小组。

获取原文
获取原文并翻译 | 示例
           

摘要

From October 1997 to November 1998, 1,180 respiratory tract isolates of Streptococcus pneumoniae were collected from 18 medical centers in 9 of the 10 Canadian provinces. Penicillin-intermediate and -resistant isolates occurred at rates of 14.8 and 6.4%, respectively, and these rates varied considerably by geographic region. Trimethoprim-sulfamethoxazole, tetracycline, and macrolide rates of nonsusceptibility were 12.2, 10.6, and 8.0 to 9.3%, respectively. The most potent agents studied were newer fluoroquinolones.
机译:从1997年10月至1998年11月,从加拿大10个省中的9个省的18个医疗中心收集了1,180个呼吸道分离的肺炎链球菌。青霉素中间菌株和耐药菌株分别以14.8%和6.4%的比率发生,并且这些比率随地理区域的不同而有很大差异。甲氧苄氨嘧啶,磺胺甲恶唑,四环素和大环内酯类药物的不敏感率分别为12.2%,10.6%和8.0至9.3%。研究的最有效的药物是较新的氟喹诺酮类药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号